click below
click below
Normal Size Small Size show me how
ganglion blockers
clinical neuro 3
| Question | Answer |
|---|---|
| hypertensive emergencies | trimethaphan |
| dissecting aortic aneurysm | trimethaphan |
| adjunct to nicotine patch | mecamylamine |
| CNS adverse effects | tremor, chorea, mental disturbances |
| CNS effects esp common with | mecamylamine |
| Eye adverse effects | cycloplegia, blurred vision |
| CV adverse effects | dec BV tone, severe orthostatic hypotension, tachycardia |
| GI adverse effects | dec motility, constipation |
| GU adverse effects (in men) | urinary retention, ED, impaired ejaculation |
| effects on sweating | decreased |
| depolarizer | succinylcholine |
| short-acting non-depolarizer | nivacurium |
| long-acting non-depolarizer | pancuronium, doxacurium |
| intermediate-acting non-depolarizer | atracurium, cisatracurium, rocuronium, vecuronium |
| effect of advanced age on non-depolarizers | prolongs duration of action by decreasing clearance |
| cisatracurium | non-depolarizer, isoquinoline family |
| MOA of non-depolarizers in small doses | compete w/Ach at nicotinic receptor |
| MOA of non-depolarizers in large doses | enter pore of channel and dec sensitivity to neostigmine/edrophonium |
| GI absorption of non-depolarizers | poor |
| non-depolarizers & BBB | can't cross |
| increased response to non-depolarizers when also taking | inhaled anesthetics, aminoglycoside antibiotics, tetracyclines, Ca++ channel blockers |
| atracurium metabolism | hydrolyzed by plasma esterase |
| cisatracurium | isomer of atracurium; undergoes hoffman degradation |
| DOC for pts w/impaired renal/hepatic functions | cisatracurium |
| releases histamine at high doses | atracurium |
| minimal CV/resp effects | intermediate-acting non-depolarizers |
| MOA of sugammadex | reverses actions of steroid blockers by forming water-soluble complexes with drug and removing it from NMJ |
| initial fasciulations with subsequent paralysis | depolarizers |
| no antidote, irreversible effect | depolarizers |
| could produce apnea | depolarizers |
| contraindications of succinylcholine | unhealed skeletal m injury (ie - severe burn/trauma) |
| less commonly used in peds due to hyperkalemia risk | succinylcholine |
| may cause post-op myalgia | succinylcholine |
| risk of malignant hyperthermia | succinylcholine |
| can be reversed by anticholinesterase agents | non-depolarizers |
| increase tetanic fade | non-depolarizers |